Viking Therapeutics (VKTX) Reports Q2 Loss of $0.22/Share

August 10, 2016 7:08 AM EDT
Get Alerts VKTX Hot Sheet
Trade VKTX Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.22), versus ($1.07) reported last year.

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment